+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Steroid Injections Market by Molecule Type (Dexamethasone, Hydrocortisone, Methylprednisolone), Treatment Type (Joint Injections, Soft Tissue Injections, Spinal Injections), Patient Type, Therapeutic Indication, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Steroid Injections Market by Molecule Type (Dexamethasone, Hydrocortisone, Methylprednisolone), Treatment Type (Joint Injections, Soft Tissue Injections, Spinal Injections), Patient Type, Therapeutic Indication, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Steroid Injections Market by Molecule Type (Dexamethasone, Hydrocortisone, Methylprednisolone), Treatment Type (Joint Injections, Soft Tissue Injections, Spinal Injections), Patient Type, Therapeutic Indication, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012190
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The steroid injections market is undergoing rapid transformation, shaped by innovation in delivery, shifts in clinical practice, and changing patient needs. Decision-makers require actionable intelligence to navigate complexities in supply chains, technology adoption, and regulatory compliance, as this sector responds to heightened demand for effective musculoskeletal and inflammatory therapies.

Market Snapshot: Steroid Injections Market Size and Trajectory

The Steroid Injections Market grew from USD 4.29 billion in 2024 to USD 4.90 billion in 2025. It is expected to continue growing at a CAGR of 13.65%, reaching USD 9.26 billion by 2030. These figures reflect a robust market shaped by increased demand for minimally invasive interventions and advancements in both drug formulation and delivery technologies.

Scope & Segmentation

  • Molecule Types: Includes dexamethasone, hydrocortisone, methylprednisolone, and triamcinolone, each distinguished by unique potency and formulation innovations.
  • Treatment Types: Covers joint injections (large and small joints), soft tissue injections (bursa, ligament, tendon), and spinal injections (epidural, intrathecal), encompassing the full suite of clinical applications.
  • Patient Types: Addresses adult, pediatric, and geriatric cohorts with tailored research into safety profiles and optimized dosing regimens.
  • Therapeutic Indications: Targets conditions such as back pain (lower, upper, sciatica), bursitis, osteoarthritis, rheumatoid arthritis, and tendonitis, reflecting the diversity of clinical needs addressed by steroid injections.
  • End Users: Ambulatory surgical centers, clinics, general and specialty hospitals form the core avenues for product utilization.
  • Distribution Channels: Hospital pharmacies, online outlets, and retail pharmacies—both chain and independent—drive product accessibility and patient reach.
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Italy, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and additional key markets).
  • Leading Companies: Analysis includes Pfizer Inc., Novartis AG, Bayer AG, Johnson & Johnson, AbbVie Inc., Merck & Co., Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Bristol-Myers Squibb Company.

Steroid Injections Market: Key Takeaways

  • Imaging and injection technology improvements are elevating procedural accuracy and enabling personalized patient care pathways.
  • Regulators are accelerating approvals for advanced corticosteroid formulations with enhanced safety and sustained-release properties, fueling competitive product innovation.
  • End users such as specialty centers and clinics are embracing digital health integration for better monitoring, adherence, and real-time therapy adjustments.
  • Pharmaceutical firms are differentiating through proprietary delivery systems, combination therapies, and value-based reimbursement contracts.
  • Segmented approaches address the specific priorities of adult, pediatric, and geriatric cohorts, expanding market reach across demographic profiles.
  • Regional strategies are essential, as product adoption and patient access diverge by healthcare infrastructure and regulatory environments.

Tariff Impact: Evolving Trade and Supply Chain Dynamics

  • 2025 U.S. tariff adjustments on corticosteroid APIs are increasing production costs, compelling manufacturers to revamp procurement by prioritizing domestic and regional sourcing strategies.
  • Supply chain leaders are optimizing vendor portfolios and logistics, using analytics to manage costs and build operational resilience.
  • Some organizations are adopting value-based pricing models and developing innovations that warrant premium positioning to maintain margins amid fiscal pressures.

Methodology & Data Sources

This report utilizes structured interviews with clinical experts, supply chain leaders, and payers, combined with in-depth secondary research spanning medical literature, regulatory documents, and industry publications. Data triangulation and quantitative modeling underpin the validation of all market trends and insights.

Why This Report Matters

  • Empowers decision-makers to benchmark commercial strategy, investment planning, and R&D priorities within a shifting steroid injections market landscape.
  • Delivers clear, actionable segmentation insights for optimizing operational efficiency and channeling resources toward the most profitable and strategically aligned opportunities.
  • Enables informed navigation of evolving policy, supply chain, and competitive dynamics affecting steroid injection therapies worldwide.

Conclusion

Senior leaders in the steroid injections market can leverage this intelligence to anticipate and respond to regulatory, technological, and competitive shifts. A data-driven, adaptive approach will support sustainable growth and value delivery as the sector continues its dynamic evolution.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of targeted intra-articular steroid formulations with sustained release profiles
5.2. Expansion of biosimilar corticosteroid injections driving cost competition in emerging markets
5.3. Integration of telehealth platforms for remote monitoring and administration of steroid injections
5.4. Rising patient demand for minimally invasive ultrasound-guided steroid injection procedures in orthopedics
5.5. Regulatory pressure on off-label steroid injection practices leading to stricter compliance protocols
5.6. Development of combination therapies pairing corticosteroids with hyaluronic acid for joint pain relief
5.7. Sustainability initiatives in single-use syringe and vial packaging for steroid injection products
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Steroid Injections Market, by Molecule Type
8.1. Introduction
8.2. Dexamethasone
8.3. Hydrocortisone
8.4. Methylprednisolone
8.5. Triamcinolone
9. Steroid Injections Market, by Treatment Type
9.1. Introduction
9.2. Joint Injections
9.2.1. Large Joints
9.2.2. Small Joints
9.3. Soft Tissue Injections
9.3.1. Bursa Injections
9.3.2. Ligament Injections
9.3.3. Tendon Injections
9.4. Spinal Injections
9.4.1. Epidural
9.4.2. Intrathecal
10. Steroid Injections Market, by Patient Type
10.1. Introduction
10.2. Adult
10.3. Geriatric
10.4. Pediatric
11. Steroid Injections Market, by Therapeutic Indication
11.1. Introduction
11.2. Back Pain
11.2.1. Lower Back Pain
11.2.2. Sciatica
11.2.3. Upper Back Pain
11.3. Bursitis
11.4. Osteoarthritis
11.5. Rheumatoid Arthritis
11.6. Tendonitis
12. Steroid Injections Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.4. Hospitals
12.4.1. General Hospitals
12.4.2. Specialty Hospitals
13. Steroid Injections Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Retail Pharmacies
13.4.1. Chain Pharmacies
13.4.2. Independent Pharmacies
14. Americas Steroid Injections Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Steroid Injections Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Steroid Injections Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Novartis AG
17.3.3. Bayer AG
17.3.4. Johnson & Johnson
17.3.5. AbbVie Inc.
17.3.6. Merck & Co., Inc.
17.3.7. Roche Holding AG
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Viatris Inc.
17.3.10. Bristol-Myers Squibb Company
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. STEROID INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. STEROID INJECTIONS MARKET: RESEARCHAI
FIGURE 28. STEROID INJECTIONS MARKET: RESEARCHSTATISTICS
FIGURE 29. STEROID INJECTIONS MARKET: RESEARCHCONTACTS
FIGURE 30. STEROID INJECTIONS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSA INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSA INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LIGAMENT INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LIGAMENT INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDON INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDON INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRATHECAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LOWER BACK PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LOWER BACK PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SCIATICA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SCIATICA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL STEROID INJECTIONS MARKET SIZE, BY UPPER BACK PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL STEROID INJECTIONS MARKET SIZE, BY UPPER BACK PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDONITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDONITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL STEROID INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL STEROID INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 158. CANADA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 159. CANADA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 160. CANADA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 161. CANADA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 162. CANADA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 163. CANADA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 164. CANADA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 165. CANADA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. CANADA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 168. CANADA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 169. CANADA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 170. CANADA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 171. CANADA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. CANADA STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. CANADA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. CANADA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. CANADA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 178. CANADA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 179. MEXICO STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 192. MEXICO STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 193. MEXICO STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 194. MEXICO STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 195. MEXICO STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. MEXICO STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. MEXICO STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. MEXICO STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 301. GERMANY STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 302. GERMANY STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 303. GERMANY STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 304. GERMANY STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 305. GERMANY STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 306. GERMANY STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 307. GERMANY STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 308. GERMANY STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 309. GERMANY STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2025-2030 (USD MILLION)
TABLE 311. GERMANY STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 312. GERMANY STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 313. GERMANY STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 314. GERMANY STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 315. GERMANY STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2024 (USD MILLION)
TABLE 316. GERMANY STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2025-2030 (USD MILLION)
TABLE 317. GERMANY STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. GERMANY STEROID INJECTIONS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. GERMANY STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. GERMANY STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. GERMANY STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 324. GERMANY STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 325. FRANCE STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 326. FRANCE STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 327. FRANCE STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 328. FRANCE STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 329. FRANCE STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2024 (USD MILLION)
TABLE 330. FRANCE STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2025-2030 (USD MILLION)
TABLE 331. FRANCE STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2024 (USD MILLION)
TABLE 332. FRANCE STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2025-2030 (USD MILLION)
TABLE 333. FRANCE STEROID INJECTIONS MARKET SIZE, BY SPIN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Steroid Injections market report include:
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Bristol-Myers Squibb Company

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.26 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Joint Pain Injections Market Report 2025 - Product Image

Joint Pain Injections Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Osteoarthritis Injectables - Global Strategic Business Report - Product Image

Osteoarthritis Injectables - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Facet-Joint Injection Global Market Report 2025 - Product Image

Facet-Joint Injection Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Viscosupplementation Injection Market by Product Type (Cross Linked Hyaluronic Acid, Non Cross Linked Hyaluronic Acid), Application Site (Hip, Knee, Shoulder), End User, Distribution Channel, Price Tier, Patient Age Group - Global Forecast 2025-2030 - Product Image

Viscosupplementation Injection Market by Product Type (Cross Linked Hyaluronic Acid, Non Cross Linked Hyaluronic Acid), Application Site (Hip, Knee, Shoulder), End User, Distribution Channel, Price Tier, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From

About the Steroid Injections Market

The steroid injections market is a subset of the broader infusions and injectables sector, focusing on products that deliver steroids directly into the body tissues, including joints, muscles, and the spine. Steroids, which are synthetic drugs that closely resemble cortisol, a hormone that the body produces naturally, are used to reduce inflammation and suppress the immune system. They are commonly prescribed for a range of conditions including arthritis, back pain, and various inflammatory diseases. The market comprises a variety of steroid types, including cortisone, methylprednisolone, and triamcinolone, among others. These injections are often administered in outpatient settings like clinics and hospitals by healthcare professionals, including doctors and nurses, who are skilled in performing these procedures. The sector is influenced by factors such as the prevalence of chronic diseases, advancements in drug formulations, and improvements in administration techniques, providing patients with pain management and symptomatic relief options. Some notable players in the steroid injections market include Pfizer Inc., Novartis AG, Merck & Co., Inc., Johnson & Johnson, and Bristol-Myers Squibb Company. These companies are engaged in the production and distribution of steroid injectables and continuously invest in research and development to improve the efficacy and safety profiles of their products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.